Cargando…

Renin, Angiotensin II, and the Journey to Evidence-based Individual Treatment Effects

Detalles Bibliográficos
Autores principales:	Casey, Jonathan D., Semler, Matthew W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605191/ https://www.ncbi.nlm.nih.gov/pubmed/32749864 http://dx.doi.org/10.1164/rccm.202007-2731ED

Ejemplares similares

Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation
por: Chappell, Mark C
Publicado: (2010)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Inhibition of the renin-angiotensin system during fetal kidney development
por: Park, Eujin
Publicado: (2020)

The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies
por: Ortiz, Rudy M., et al.
Publicado: (2023)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Cognitive decline: mechanisms and proposed role of the renin–angiotensin–aldosterone system
por: Opie, Lionel H
Publicado: (2014)

Do inhibitors of the renin–angiotensin system prevent chronic kidney disease?
por: Rayner, Brian
Publicado: (2010)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

The Yin and Yang of the Renin–Angiotensin–Aldosterone System in Acute Kidney Injury
por: Legrand, Matthieu, et al.
Publicado: (2021)

GENETIC INFLUENCE ON THE RENIN-ANGIOTENSIN SYSTEM : EVIDENCE FOR A RENIN INHIBITOR IN HYPERTENSION-PRONE RATS
por: Iwai, Junichi, et al.
Publicado: (1970)

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
por: Silva-Cardoso, José, et al.
Publicado: (2022)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin–angiotensin system
por: Wang, Fei, et al.
Publicado: (2015)

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
por: Karadağ, Bilgehan
Publicado: (2020)

Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2
por: Angeli, Fabio, et al.
Publicado: (2023)

No evidence for a local renin-angiotensin system in liver mitochondria
por: Astin, Ronan, et al.
Publicado: (2013)

Molecular evidence of tissue renin-angiotensin systems: A focus on the brain
por: Sakai, Koji, et al.
Publicado: (2005)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

How I manage a difficult intubation
por: Casey, Jonathan D., et al.
Publicado: (2019)

Renin-Angiotensin-Aldosterone System Inhibition and Mineralocorticoid Receptor Antagonists: The Overriding Importance of Enablers and Dampers
por: Epstein, Murray
Publicado: (2021)

Renin-Angiotensin System Inhibitors in Advanced CKD: a #NephJC Editorial on STOP-ACEi
por: Thanabalasingam, Susan, et al.
Publicado: (2023)

Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
por: Park, Jae-Hyeong
Publicado: (2023)

Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma
por: Jeon, Soo Ji, et al.
Publicado: (2020)

Chronic effects of lead on the renin-angiotensin system.
por: Vander, A J
Publicado: (1988)

Nanoparticle approaches for the renin-angiotensin system
por: Hettiarachchi, Sajini D., et al.
Publicado: (2023)

Renin Angiotensin System Inhibition as treatment for Covid-19?
por: Williams, Professor Bryan
Publicado: (2021)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Is angiotensin-(3–4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin–angiotensin system?
por: Dias, Juliana, et al.
Publicado: (2017)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

A journey into clinical evidence: from case reports to mixed treatment comparisons
por: Biondi-Zoccai, G, et al.
Publicado: (2011)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

The Role of the Renin-Angiotensin System in Hepatic Fibrosis
por: Lubel, J.S., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5r13fjn9kpcna7h2fvgksqj87e